Healthcare Global Enterprises Limited has informed the Exchange that Record date fixed for the purpose of Rights issue is 02-Mar-2026.
HCG · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
HCG will raise up to ₹425 crore (₹42,500 lakhs) through a rights issue of equity shares. The company will issue 82,94,566 shares at ₹512 per share (face value ₹10 + premium ₹502). Existing shareholders will be offered 1 new share for every 17 shares held. The record date to determine eligibility is March 2, 2026. The issue opens on March 11 and closes on March 25, 2026, with shares expected to list by April 1, 2026. Post-issue, total outstanding shares will rise from 14.10 crore to 14.93 crore, assuming full subscription. The Letter of Offer has been approved for filing with SEBI and the stock exchanges.
Shareholders must hold HCG shares by March 2, 2026 to receive rights entitlements, which they can either subscribe to or renounce. The relatively small entitlement ratio (1:17) means modest dilution for existing holders. The capital raise is aimed at funding growth, but the stock may see short-term pressure near the record date as it typically trades ex-rights shortly after.